Antiviral drug allergy.
Milpied-Homsi B, Moran EM, Phillips EJ.
Immunol Allergy Clin North Am · research-article; review; journal article · DOI 10.1016/j.iac.2014.04.011 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för tipranavir. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
11 träffarFrequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor.
Barber TJ, Harrison L, Asboe D, Williams I, Kirk S, Gilson R, Bansi L, Pillay D, Dunn D, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort (UK CHIC) Study Steering Committees.
J Antimicrob Chemother · research support, non-u.s. gov't; journal article · DOI 10.1093/jac/dkr569Boosted tipranavir versus darunavir in treatment-experienced patients: observational data from the randomized POTENT trial.
Elgadi MM, Piliero PJ.
Drugs R D · comparative study; brief-report; randomized controlled trial; journal article · DOI 10.2165/11596340-000000000-00000Emerging HIV-1 resistance to tipranavir and darunavir in patients with virological failure to first-generation protease inhibitors in Taiwan.
Hsieh SM, Chang SY, Hung CC, Sheng WH, Chen MY, Chang SC.
Int J STD AIDS · research support, non-u.s. gov't; journal article · DOI 10.1258/ijsa.2009.009007The higher barrier of darunavir and tipranavir resistance for HIV-1 protease.
Wang Y, Liu Z, Brunzelle JS, Kovari IA, Dewdney TG, Reiter SJ, Kovari LC.
Biochem Biophys Res Commun · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1016/j.bbrc.2011.08.045Comparison of drug resistance scores for tipranavir in protease inhibitor-naive patients infected with HIV-1 B and non-B subtypes.
Stürmer M, Stephan C, Gute P, Knecht G, Bickel M, Brodt HR, Doerr HW, Gürtler L, Lecocq P, van Houtte M.
Antimicrob Agents Chemother · research-article; journal article · DOI 10.1128/aac.00611-11Switch from enfuvirtide to raltegravir lowers plasma concentrations of darunavir and tipranavir: a pharmacokinetic substudy of the EASIER-ANRS 138 trial.
Goldwirt L, Braun J, de Castro N, Charreau I, Barrail-Tran A, Delaugerre C, Raffi F, Lascoux-Combe C, Aboulker JP, Taburet AM, Molina JM.
Antimicrob Agents Chemother · research-article; journal article · DOI 10.1128/aac.01827-10Pharmacokinetic profile in late pregnancy and cord blood concentration of tipranavir and enfuvirtide.
Weizsaecker K, Kurowski M, Hoffmeister B, Schürmann D, Feiterna-Sperling C.
Int J STD AIDS · journal article; case reports · DOI 10.1258/ijsa.2009.009166Predicting tipranavir and darunavir resistance using genotypic, phenotypic, and virtual phenotypic resistance patterns: an independent cohort analysis of clinical isolates highly resistant to all other protease inhibitors.
Talbot A, Grant P, Taylor J, Baril JG, Liu TF, Charest H, Brenner B, Roger M, Shafer R, Cantin R, Zolopa A.
Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.00096-10Improving the prediction of virological response to tipranavir: the development and validation of a tipranavir-weighted mutation score.
Schapiro JM, Scherer J, Boucher CA, Baxter JD, Tilke C, Perno CF, Maggiolo F, Santoro MM, Hall DB.
Antivir Ther · validation study; journal article · DOI 10.3851/imp1670In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV.
Hazen R, Harvey R, Ferris R, Craig C, Yates P, Griffin P, Miller J, Kaldor I, Ray J, Samano V, Furfine E, Spaltenstein A, Hale M, Tung R, St Clair M, Hanlon M, Boone L.
Antimicrob Agents Chemother · research-article; journal article · DOI 10.1128/aac.00401-07